abstract |
Fibrinogen receptor antagonists of the general formula: X-A-Y-Z-BIand which includes, for example, the compounds of formula <IMAGE> IV are useful for inhibiting the binding of fibrinogen to blood platelets, inhibiting the aggregation of blood platelets, treating thrombus formation or embolus formation, and preventing thrombus or embolus formation. |